These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 30270717)

  • 41. The Look AHEAD Trial: A Review and Discussion Of Its Outcomes.
    Pi-Sunyer X
    Curr Nutr Rep; 2014 Dec; 3(4):387-391. PubMed ID: 25729633
    [TBL] [Abstract][Full Text] [Related]  

  • 42. (4) Foundations of care: education, nutrition, physical activity, smoking cessation, psychosocial care, and immunization.
    American Diabetes Association
    Diabetes Care; 2015 Jan; 38 Suppl():S20-30. PubMed ID: 25537702
    [No Abstract]   [Full Text] [Related]  

  • 43. Enteral nutrition formula selection: current evidence and implications for practice.
    Brown B; Roehl K; Betz M
    Nutr Clin Pract; 2015 Feb; 30(1):72-85. PubMed ID: 25516537
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gut microbiota and metabolic syndrome.
    Festi D; Schiumerini R; Eusebi LH; Marasco G; Taddia M; Colecchia A
    World J Gastroenterol; 2014 Nov; 20(43):16079-94. PubMed ID: 25473159
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Standards of medical care in diabetes--2014.
    American Diabetes Association
    Diabetes Care; 2014 Jan; 37 Suppl 1():S14-80. PubMed ID: 24357209
    [No Abstract]   [Full Text] [Related]  

  • 46. Position of the academy of nutrition and dietetics: dietary fatty acids for healthy adults.
    Vannice G; Rasmussen H
    J Acad Nutr Diet; 2014 Jan; 114(1):136-53. PubMed ID: 24342605
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nutrition therapy.
    ; Dworatzek PD; Arcudi K; Gougeon R; Husein N; Sievenpiper JL; Williams SL
    Can J Diabetes; 2013 Apr; 37 Suppl 1():S45-55. PubMed ID: 24070963
    [No Abstract]   [Full Text] [Related]  

  • 48. The study of glycemic index of Gen-Premium.
    Boonyavarakul A
    J Med Assoc Thai; 2013 Aug; 96(8):911-6. PubMed ID: 23991596
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical and economic benefits associated with the achievement of both HbA1c and LDL cholesterol goals in veterans with type 2 diabetes.
    Shi L; Ye X; Lu M; Wu EQ; Sharma H; Thomason D; Fonseca VA
    Diabetes Care; 2013 Oct; 36(10):3297-304. PubMed ID: 23801723
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Meal replacements for weight loss in type 2 diabetes in a community setting.
    Keogh JB; Clifton PM
    J Nutr Metab; 2012; 2012():918571. PubMed ID: 23091707
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of postprandial glycaemia on health and prevention of disease.
    Blaak EE; Antoine JM; Benton D; Björck I; Bozzetto L; Brouns F; Diamant M; Dye L; Hulshof T; Holst JJ; Lamport DJ; Laville M; Lawton CL; Meheust A; Nilson A; Normand S; Rivellese AA; Theis S; Torekov SS; Vinoy S
    Obes Rev; 2012 Oct; 13(10):923-84. PubMed ID: 22780564
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Functional herbal food ingredients used in type 2 diabetes mellitus.
    Perera PK; Li Y
    Pharmacogn Rev; 2012 Jan; 6(11):37-45. PubMed ID: 22654403
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
    Inzucchi SE; Bergenstal RM; Buse JB; Diamant M; Ferrannini E; Nauck M; Peters AL; Tsapas A; Wender R; Matthews DR
    Diabetologia; 2012 Jun; 55(6):1577-96. PubMed ID: 22526604
    [No Abstract]   [Full Text] [Related]  

  • 54. Postprandial substrate use in overweight subjects with the metabolic syndrome after isomaltulose (Palatinose™) ingestion.
    König D; Theis S; Kozianowski G; Berg A
    Nutrition; 2012 Jun; 28(6):651-6. PubMed ID: 22264450
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reduced glycaemic and insulinaemic responses following trehalose and isomaltulose ingestion: implications for postprandial substrate use in impaired glucose-tolerant subjects.
    van Can JG; van Loon LJ; Brouns F; Blaak EE
    Br J Nutr; 2012 Oct; 108(7):1210-7. PubMed ID: 22172468
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Beneficial effects of dietary fish-oil-derived monounsaturated fatty acids on metabolic syndrome risk factors and insulin resistance in mice.
    Yang ZH; Miyahara H; Mori T; Doisaki N; Hatanaka A
    J Agric Food Chem; 2011 Jul; 59(13):7482-9. PubMed ID: 21627145
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Point: postprandial glucose levels are a clinically important treatment target.
    Ceriello A
    Diabetes Care; 2010 Aug; 33(8):1905-7. PubMed ID: 20668158
    [No Abstract]   [Full Text] [Related]  

  • 58. Glycaemic control in type 2 diabetes: targets and new therapies.
    Tahrani AA; Piya MK; Kennedy A; Barnett AH
    Pharmacol Ther; 2010 Feb; 125(2):328-61. PubMed ID: 19931305
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A whey protein supplement decreases post-prandial glycemia.
    Petersen BL; Ward LS; Bastian ED; Jenkins AL; Campbell J; Vuksan V
    Nutr J; 2009 Oct; 8():47. PubMed ID: 19835582
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Glycemic response and health--a systematic review and meta-analysis: the database, study characteristics, and macronutrient intakes.
    Livesey G; Taylor R; Hulshof T; Howlett J
    Am J Clin Nutr; 2008 Jan; 87(1):223S-236S. PubMed ID: 18175762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.